| 000 | 01754 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513131106.0 | ||
| 264 | 0 | _c19971229 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0340-6199 | ||
| 024 | 7 |
_a10.1007/s004310050708 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIlveskoski, I | |
| 245 | 0 | 0 |
_aGrowth impairment and growth hormone therapy in children treated for malignant brain tumours. _h[electronic resource] |
| 260 |
_bEuropean journal of pediatrics _cOct 1997 |
||
| 300 |
_a764-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBody Height _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCranial Irradiation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDwarfism _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xdrug effects |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPituitary-Adrenal System _xdrug effects |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 700 | 1 | _aSaarinen, U M | |
| 700 | 1 | _aWiklund, T | |
| 700 | 1 | _aSipilä, I | |
| 700 | 1 | _aMäkipernaa, A | |
| 700 | 1 | _aPerkkiö, M | |
| 700 | 1 | _aLanning, M | |
| 700 | 1 | _aSalmi, T T | |
| 700 | 1 | _aPihko, H | |
| 773 | 0 |
_tEuropean journal of pediatrics _gvol. 156 _gno. 10 _gp. 764-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s004310050708 _zAvailable from publisher's website |
| 999 |
_c9335030 _d9335030 |
||